Nicotine Polacrilex Lozenge
Product Images NDC 71335-2729

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 71335-2729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (713352729 E Label)

This text provides guidelines for using nicotine lozenges to help quit smoking. It includes instructions on dosage based on when the first cigarette of the day is smoked, as well as a 12-week schedule for gradually reducing lozenge usage. Users are advised to read the enclosed user guide before starting the treatment. It is recommended to start using the lozenges on the designated quit day after consulting a doctor if under 18 years of age.*

FDA Label Image

Wallet Card Image 1 (Image 01)

FDA Label Image

Wallet Card Image 2 (Image 02)

This text provides useful contact information for seeking help with health-related issues such as lung diseases, cancer, and heart health. It also suggests the support of a "Quitting Buddy" or "Friend who has Quit" for assistance in lifestyle changes.*

FDA Label Image

Smoke Free Habits Logo (Image 03)

Free & Personalized Support Plan offered by IS_IokeFreeabits.com for assistance and guidance in achieving your goals. Personalized support and resources to help you establish and maintain healthy habits.*

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Reminder Stickers (Image 05)

This text provides a schedule for reminders to be placed on your calendar related to smoking cessation using lozenges. It includes guidelines for when to take the lozenges in the first week, at week 7, week 10, and 12 weeks after quitting smoking. The reminders specify the frequency of taking the lozenges and indicate the step 3 for the ex-smoker.*

FDA Label Image

Label (Lbl713352729)

This is a package insert for a Nicotine Polacrilex Lozenge, which is a stop smoking aid that helps reduce withdrawal symptoms and nicotine cravings associated with quitting smoking. The insert provides information on the active ingredients, warnings, directions for use, storage instructions, and contact information for emergencies. It also lists the inactive ingredients and details about the product such as the size and the manufacturer. The text emphasizes the importance of following proper usage guidelines and cautions against exceeding the recommended dosage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.